Dyne Therapeutics, Inc.
DYN • NASDAQ
Dyne Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO John G. Cox, with a market cap of $3.2B.
Market Cap$3.2B
Employees143.0
CEOJohn G. Cox
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
Dyne Therapeutics, Inc. FAQ
Common questions about Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 7, 2026.
Dyne Therapeutics, Inc. has approximately 143 employees.